Harm Reduction Group Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Marius Arnesen
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | no data |
CEO ownership | 5.9% |
Management average tenure | no data |
Board average tenure | 3.9yrs |
Recent management updates
Recent updates
Market Cool On Harm Reduction Group AB (publ)'s (NGM:NOHARM) Revenues Pushing Shares 31% Lower
Nov 07The Market Doesn't Like What It Sees From Harm Reduction Group AB (publ)'s (NGM:NOHARM) Revenues Yet As Shares Tumble 45%
Aug 06Harm Reduction Group AB (publ)'s (NGM:NOHARM) Shares Leap 26% Yet They're Still Not Telling The Full Story
Jun 22Is Harm Reduction Group (NGM:NOHARM) Using Debt In A Risky Way?
May 29Harm Reduction Group AB (publ) (NGM:NOHARM) Might Not Be As Mispriced As It Looks After Plunging 25%
Apr 24Market Cool On Harm Reduction Group AB (publ)'s (NGM:NOHARM) Revenues Pushing Shares 30% Lower
Mar 05Health Check: How Prudently Does Harm Reduction Group (NGM:NOHARM) Use Debt?
Feb 29Further Upside For Harm Reduction Group AB (publ) (NGM:NOHARM) Shares Could Introduce Price Risks After 32% Bounce
Jan 05It's Down 28% But Harm Reduction Group AB (NGM:NOHARM) Could Be Riskier Than It Looks
Sep 05Does Harm Reduction Group (NGM:NOHARM) Have A Healthy Balance Sheet?
Sep 01Companies Like SealWacs (NGM:SEAL) Are In A Position To Invest In Growth
Dec 28CEO
Marius Arnesen (43 yo)
no data
Tenure
Mr. Marius Arnesen serves as Chief Executive Officer of Harm Reduction Group AB (publ) (formerly known as Norse Impact AB (publ)) (formerly known as SealWacs AB (publ)).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CFO & Director | 2.9yrs | no data | 3.8% SEK 453.3k | |
Chairman | 12.9yrs | no data | 0.23% SEK 27.2k | |
Director | 3.9yrs | no data | 3.84% SEK 458.1k | |
Director | 3.9yrs | no data | 0.72% SEK 86.4k | |
Director | 3.9yrs | no data | 3.47% SEK 413.8k |
3.9yrs
Average Tenure
58yo
Average Age
Experienced Board: NOHARM's board of directors are considered experienced (3.9 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/30 23:16 |
End of Day Share Price | 2024/12/30 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Harm Reduction Group AB (publ) is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Mattias Ehrenborg | Redeye |
Christian Binder | Redeye |